`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`AMNEAL PHARMACEUTICALS LLC
`AND AMNEAL PHARMACEUTICALS OF NEW YORK, LLC.,
`Petitioner
`
`v.
`
`ALLERGAN, INC.
`Patent Owner
`_____________________
`
`CASE IPR2018-0608
`Patent 9,161,926
`_____________________
`
`
`TRANSMITTAL LETTER ACCOMPANYING
`SUBMISSION OF EXHIBIT 1007
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`Case IPR2018-00608
`Patent No. 9,161,926
`
`
`Further to the Board’s March 8, 2018 Notice of Filing Date Accorded (Paper
`
`6), Petitioner Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New
`
`York, LLC. hereby submit a corrected version of Exhibit 1007 (U.S. Patent
`
`Publication No. 2006/0204526 (“Lathrop”)).
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`Date: March 13, 2018
`
`
`
`
`
`________________________
`
` Dennies Varughese, Pharm.D.
`Lead Counsel for Petitioners
`1100 New York Avenue, N.W. Registration No. 61,868
`Washington, D.C.20005-3934
`
`(202) 371-2600
`9134547.1
`
`
`
`
`
`- 1 -
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`The undersigned hereby certifies that the above-captioned "Transmittal Letter
`
`Accompanying Submission of Exhibit 1007," along with Exhibit 1007, were served
`
`in their entirety on March 13, 2018, via email on the following:
`
`Scott E. Kamholz
`Jessica L. Parezo
`
`IPR2018-00608@cov.com
`
`
` Respectfully submitted,
`
`
`
`
`Date: March 13, 2018
`
`_______________________
` Dennies Varughese, Pharm.D.
`Lead Counsel for Petitioners
`1100 New York Avenue, N.W. Registration No. 61,868
`Washington, D.C.20005-3934
`
`(202) 371-2600
`
`
`
`
`
`
`
`
`